CTTE 2020 – Cell-Based Therapies & Tissue Engineering

This course focuses on these cell-based therapies with emphasis on the new basic principles of Tissue Engineering and the detailed information and protocols for accomplishing these therapies. This course is intended for graduate students, post-graduate students, and health science professionals who are interested in Tissue Engineering with emphasis on the principles and detailed protocols used or being modeled for direct clinical use.

The course involves morning lectures by eminent scholars, and afternoon laboratories and lectures on the “how to” of cell culture and cell-scaffold interactions. These visual laboratories provide insight into the complex, multi-step technologies of today and tomorrow and provide the basis for standardizing cell-based technologies between various laboratories throughout the world.

Click above to be redirected to the 2020 course website
August 10 — August 12, 2020
2020 program is online


The Regulatory Environment of Regenerative Medicine: A Changing Landscape
Scott Bruder, M.D., Ph.D. – Founder and CEO, Bruder Consulting & Venture Group
Monday, August 10, 2020. Clapp Hall, room 108. 4:30 – 5:30 p.m.

(This lecture is open to the University and its Affiliates)

12th Business of Regenerative Medicine: Defining and creating value

The symposium will include lectures delivered by established entrepreneurs, industry and scientific leaders, panel discussions, networking events and more. It is attended by entrepreneurs, junior and senior scientists, business executives, investors and analysts, technology transfer and development personnel, managers in the government, non-profit and profit sectors.

The Symposium is hosted by the Harvard Business School in partnership with Center for Cellular Immunotherapies and the Institute for Regenerative Medicine at the University of Pennsylvania, Case Western Reserve University, the Harvard Stem Cell Institute, the Parker H. Petit for Institute Bioengineering and Bioscience at Georgia Tech, and the Centre for Commercialization of Regenerative Medicine.
July 15 — July 16, 2019
Harvard Business School, Aldrich Hall, Soldiers Field Road, Boston, MA

Program is online


A new certification course offered by our NCRM colleagues in collaboration with Rutgers‘ NIH Training Grant “Translational Research in Regenerative Medicine” and will run for 30 weeks (15 weeks per semester). This global initiative, will link stem cell and regenerative medicine centers, investigators, and students around the world to provide first-class educational and research opportunities. Consortium members will work together (1) to develop strong educational and research programs, (2) to facilitate the introduction of students and other colleagues to the field, and (3) to provide an enabling plat-form for collaborative development in the areas of stem cell and regenerative medicine. RENEW will be internet-based, which will enable presentations from participating institutions around the world.

The topics include fundamental stem cell biology, stem cell isolation, “dry lab technology,” specific preclinical applications, as well as such common issues in the field as signal transduction, cell proliferation, differentiation, assays in phenotypes, preclinical animal models, clinical trial design and regulatory issues.


Click above to be redirected to the Edheads website

Edheads is an online educational resource that provides free science and math games and activities that promote critical thinking. Edheads partners with corporations, universities, and school systems throughout the United States, Edheads has been recognized by almost every major award on the Web for excellent educational content.